Left ventricular function changes after cardiomyoplasty in patients with dilated cardiomyopathy

Area of Science:

• Cardiology
• Cardiac Surgery
• Regenerative Medicine

Background:

• Severe myocardial failure presents significant therapeutic challenges.
• Dilated cardiomyopathy and Chagas' disease are major causes of advanced heart failure.
• Existing treatments for end-stage heart failure have limitations.

Purpose of the Study:

• To evaluate the efficacy of dynamic cardiomyoplasty in improving left ventricular function in patients with severe heart failure.
• To assess the long-term outcomes of dynamic cardiomyoplasty in patients with dilated cardiomyopathy and Chagas' disease.
• To determine the impact of dynamic cardiomyoplasty on New York Heart Association (NYHA) functional class.

Main Methods:

• Prospective study involving thirteen patients with NYHA class III or IV heart failure.
• Dynamic cardiomyoplasty procedure performed on all participants.
• Follow-up assessments included Doppler echocardiography, radioisotopic left ventricular ejection fraction, and cardiac catheterization.
• Long-term follow-up data collected for a mean of 11.5 months.

Main Results:

• No operative deaths; two late deaths during follow-up.
• Significant improvement in left ventricular segmental wall shortening (p < 0.01) and stroke volume (p < 0.01) at 3 months.
• Left ventricular ejection fraction showed improvement (p = 0.06).
• Left ventricular stroke work index increased (p < 0.01), and pulmonary wedge pressure decreased (p < 0.01).
• Functional improvements were sustained at 6 and 12 months.
• Five of nine long-term observed patients improved to NYHA class I or II.

Conclusions:

• Dynamic cardiomyoplasty is a viable treatment option for severe heart failure.
• The procedure leads to significant and sustained improvements in left ventricular function.
• Dynamic cardiomyoplasty may alter the natural progression of severe cardiomyopathies.